Role of Intracellular Calcium in Clotrimazole-Induced Alteration of Cell Cycle Inhibitors, p53 and p27, in HT29 Human Colon Adenocarcinoma Cells

  • Published : 2008.03.28


Clotrimazole (CLT), a potent antifungal drug, is known to inhibit tumor cell proliferation. In the present study, we examined the role of intracellular $Ca^{2+}$ in CLT-induced cell cycle arrest of colon adenocarcinoma HT29 cells. CLT inhibited growth of HT29 cells in a concentration-dependent manner, which was associated with inhibition of cell cycle progression at the G(1)-S phase transition and an increase in the expression of cell cycle inhibitor proteins p27 and p53. CLT also suppressed the $Ca^{2+}$ overload by A23187, a calcium ionophore, suggesting its role in modulation of intracellular $Ca^{2+}$ concentration in HT29 cells. The simultaneous application of CLT and A23187 with addition of $CaCl_2$ (1mM) to the medium significantly reversed CLT-induced p27 and p53 protein level increase and growth suppression. Our results suggest that CLT induces cell cycle arrest of colon adenocarcinoma HT29 cells via induction of p27 and p53, which may, at least in part, be mediated by alteration of intracellular $Ca^{2+}$ level.



  1. Aktas, H., Flückiger, R., Acosta, J.A., Savage, J.M., Palakurthi, S.S. and Halperin, J.A. (1998). Depletion of intracellular $Ca^{2+}$ stores, phosphorylation of eIF2alpha, and sustained inhibition of translation initiation mediate the anticancer effects of CLT. Proc Natl Acad Sci U S A. 95(14), 8280-8285
  2. Apati, A., Janossy, J., Brozik, A., Bauer, P.I. and Magocsi, M. (2003). Calcium induces cell survival and proliferation through the activation of the MAPK pathway in a human hormone-dependent leukemia cell line, TF-1. J Biol Chem. 278(11), 9235-9243
  3. Benzaquen, L.R., Brugnara, C., Byers, H.R., Gatton-Celli, S. and Halperin, J.A. (1995). CLT inhibits cell proliferation in vitro and in vivo. Nat Med. 1(6), 534-540
  4. Berridge, M.J. (1995). Calcium signalling and cell proliferation. BioEssays 17, 491-500
  5. Berridge, M.J., Lipp, P. and Bootman, M.D. (2000). The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 1(1), 11-21
  6. Brugnara, C., de Franceschi, L. and Alper, S.L. (1993). Inhibition of $Ca^{2+}$-dependent $K^+$ transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J. Clin. Invest. 92, 520-526
  7. Buolamwini, J.K. (2000). Cell cycle molecular targets in novel anticancer drug discovery. Curr Pharm Des. 6(4), 379-392
  8. Cheng, G., Liu, B.F., Yu, Y., Diglio, C. and Kuo, T.H. (1996). The exit from G(0) into the cell cycle requires and is controlled by sarco(endo)plasmic reticulum $Ca^{2+}$ pump. Arch Biochem Biophys. 329(1), 65-72
  9. Hazelton, B., Mitchell, B. and Tupper, J. (1979). Calcium, magnesium, and growth control in the WI-38 human fibroblast cell. J Cell Biol. 83(2 Pt 1), 487-498
  10. Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R.D. and Korsmeyer, S.J. (1990). Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 348(6299), 334-336
  11. Hunter, T., and Pines, J. (1994). Cyclins and cancer. II: Cyclin D and CDKCDK inhibitors come of age. Cell 79, 573-582
  12. Jager, H., Dreker, T., Buck, A., Giehl, K., Gress, T. and Grissmer, S. (2004). Blockage of intermediate-conductance $Ca^{2+}$-activated $K^+$ channels inhibit human pancreatic cancer cell growth in vitro. Mol Pharmacol. 65(3), 630-638
  13. Kahl, C.R. and Means, A.R. (2003). Regulation of cell cycle progression by calcium/calmodulin-dependent pathways. Endocr Rev. 24(6), 719-736
  14. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51(23 Pt 1), 6304-6311
  15. Khalid, M.H., Tokunaga, Y., Caputy, A.J. and Walters, E. (2005). Inhibition of tumor growth and prolonged survival of rats with intracranial gliomas following administration of CLT. J Neurosurg. 103(1), 79-86
  16. Li, M., Lee, T.W., Yim, A.P., Mok, T.S. and Chen, G.G. (2006). Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERKdependent in human non-small lung cancer cells. J Cell Physiol. 209(2), 428-438
  17. Morgan, D.O. (1995). Principles of CDK regulation. Nature. 374, 131-134
  18. Ohtsubo, M. and Roberts, J.M. (1993). Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259, 1908-1912
  19. Ouadid-Ahidouch, H., Roudbaraki, M., Ahidouch, A., Delcourt, P. and Prevarskaya, N. (2004). Cell-cycle-dependent expression of the large Ca2+-activated K+ channels in breast cancer cells. Biochem Biophys Res Commun. 316(1), 244-251
  20. Parihar, A.S., Coghlan, M.J., Gopalakrishnan, M. and Shieh, C.C. (2003). Effects of intermediate-conductance $Ca^{2+}$-activated $K^+$ channel modulators on human prostate cancer cell proliferation. Eur J Pharmacol. 471(3), 157-164
  21. Takahashi, H., Abe, M., Sugawara, T., Tanaka, K., Saito, Y., Fujimura, S., Shibuya, M. and Sato, Y. (1998). Clotrimazole, an imidazole antimycotic, is a potent inhibitor of angiogenesis. Jpn J Cancer Res. 89, 445-451
  22. Toyoshima, H. and Hunter, T. (1994). p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78, 67-74
  23. Yoshida, Y. and Aoyama, Y. (1987). Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes. Biochem. Pharmacol. 36, 229-235

Cited by

  1. Inhibitory effects of clotrimazole on TNF-α-induced adhesion molecule expression and angiogenesis vol.32, pp.4, 2009,